Cite
Assessment of formulation robustness for nano-crystalline suspensions using failure mode analysis or derisking approach.
MLA
Nakach, Mostafa, et al. “Assessment of Formulation Robustness for Nano-Crystalline Suspensions Using Failure Mode Analysis or Derisking Approach.” International Journal of Pharmaceutics, vol. 506, no. 1/2, June 2016, pp. 320–31. EBSCOhost, https://doi.org/10.1016/j.ijpharm.2016.04.043.
APA
Nakach, M., Authelin, J.-R., Voignier, C., Tadros, T., Galet, L., & Chamayou, A. (2016). Assessment of formulation robustness for nano-crystalline suspensions using failure mode analysis or derisking approach. International Journal of Pharmaceutics, 506(1/2), 320–331. https://doi.org/10.1016/j.ijpharm.2016.04.043
Chicago
Nakach, Mostafa, Jean-René Authelin, Cecile Voignier, Tharwat Tadros, Laurence Galet, and Alain Chamayou. 2016. “Assessment of Formulation Robustness for Nano-Crystalline Suspensions Using Failure Mode Analysis or Derisking Approach.” International Journal of Pharmaceutics 506 (1/2): 320–31. doi:10.1016/j.ijpharm.2016.04.043.